A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

• Valentín García-Gutiérrez,

  Affiliation Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain

  ⨯
• María T. Gómez-Casares,

  Affiliation Hematology Department, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Spain

  ⨯
• José M. Puerta,

  Affiliation Unidad de Gestión Clínica Hematología y Hemoterapia, Hospital Universitario Virgen de las Nieves, Granada, Spain

  ⨯
• Juan M. Alonso-Domínguez,

  Affiliation Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

  ⨯
• Santiago Osorio,

  Affiliation Hematology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Juan C. Hernández-Boluda,

  Affiliation Hematology Department, Hospital Clínico, Valencia, Spain

  ⨯
• Rosa Collado,

  Affiliation Genetic Laboratory, Hematology Department, Consorcio Hospital General Universitario, Valencia, Spain

  ⨯
• María J. Ramírez,

  Affiliation Hematology Department, Hospital de Jerez de la Frontera, Cádiz, Spain

  ⨯
• Fátima Ibáñez,

  Affiliation Hematology Department, Hospital San Pedro de Alcántara, Cáceres, Spain

  ⨯
• María L. Martín,

  Affiliation Hematology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain

  ⨯
• Juan D. Rodríguez-Gambarte,

  Affiliation Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain

  ⨯
• Carolina Martínez-Laperche,

  Affiliation Hematology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Montse Gómez,

  Affiliation Hematology Department, Hospital Clínico, Valencia, Spain

  ⨯
• Dolly V. Fiallo,

  Affiliation Hematology Department, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Spain

  ⨯
• Sara Redondo,

  Affiliation Hematology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Alicia Rodríguez,

  Affiliation Hematology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain

  ⨯
• Concepción Ruiz-Nuño,

  Affiliation Hematology Department, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain

  ⨯
• Juan L. Steegmann,

  Affiliation Hematology Department & IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain

  ⨯
• Antonio Jiménez-Velasco ,

  * E-mail: a.jimenez.velasco@gmail.com

  Affiliation Hematology Department, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain

  http://orcid.org/0000-0001-6421-7872

  ⨯
•  [ ... ],
• Spanish Group of Chronic Myeloid Leukemia (GELMC)

  ¶Membership of the Spanish Group of Chronic Myeloid Leukemia (GELMC) is provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]